DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Cantor Fitzgerald Reiterates Overweight on Benefitfocus, Lowers Price Target to $25

Cantor Fitzgerald analyst Steven Halper reiterates Benefitfocus (NASDAQ:BNFT) with a Overweight and lowers the price target from $47 to $25.

Benzinga · 03/04/2020 11:28

Cantor Fitzgerald analyst Steven Halper reiterates Benefitfocus (NASDAQ:BNFT) with a Overweight and lowers the price target from $47 to $25.